Gazanfer Ekinci

Gazanfer Ekinci

Auto-generated profile, based on publicly available information

Gazanfer Ekinci

Department of Radiology, Yeditepe University School of Medicine, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2021 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
OSOlcay Sah
Olcay Sah
DTDilsad Turkdogan
Dilsad Turkdogan
SKSelda Kucuk
Selda Kucuk
GTGulnur Takis
Gulnur Takis
RARuslan Asadov
Ruslan Asadov
GEGazanfer Ekinci
Gazanfer Ekinci
Malformations of cortical development,epilepsy,Bayley-III,WISC-R,DDST-II,Barkovich 2012 classification

10 December 2024 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
AAAysun Aksoy
Aysun Aksoy
CGCemal Gündoğmuş
Cemal Gündoğmuş
MKMehmet Kesi̇mEr
Mehmet Kesi̇mEr
KNKemal Nas
Kemal Nas
IDİkRam Duman
İkRam Duman
PAPami̇r Atagündüz
Pami̇r Atagündüz
Background/aim: Syndesmophyte formation appears to be site specific in Ankylosing spondylitis(AS),and new bone formation seems to occur in regions of micro-trauma that are prone to tensile forces.Pelvic and spinal parameters are unique for individuals. Pelvic tilt and sacral slope are important anatomical features that compensate in harmony in keeping the sagittal balance. After puberty, the sacral slope shapes the lumbar lordosis, whereas the pelvic incidence is set to an individual constant. This study aims to analyze the properties of pelvic parameters in AS patients with and without syndesmophyte formation in the spine after 15years of disease duration.Materials and methods:Whole spine radiographs of 104 AS patients and clinical data are analyzed according to radiographic damage in the spine.AS patients were grouped as with or without syndesmophytes. Patients with complete bridging in at least one vertebral unit were excluded. Sacral slope,pelvic tilt,pelvic incidence,and lumbar lordosis were measured. Results: The mean disease duration was 14.5 years, and 60% of AS patients were male. Groups were similar in terms of age, sex distribution,and disease duration. Although numerically higher in patients with syndesmophytes, the mean pelvic incidence of AS patients was not different between groups(55.2±13.6 vs. 57.2±15.4). The sacral slope was high in patients with lumbar syndesmophytes(p<.005).Conclusion:Sacral slope was significantly higher in patients with syndesmophytes, which in turn results in an increased lumbar lordosis. Our results imply that the individual shape of the spine affects the distribution of weight and tensile forces in AS, and some patients are possibly more prone to new bone formation due to altered repetitive micro-trauma in the general genetic background of AS.Prospective studies addressing this cross-sectional observation may contribute to the development of new treatment strategies addressing mechanical load and may aid in decreasing management cost of AS with the present biologic therapies targeting new bone formation.

12 January 2026 in Pituitary
Verified
Journal Article
Closed access
PDF file
EBERHAN BIYIKLI
ERHAN BIYIKLI
TATahsin Aybal
Tahsin Aybal
BABülent Aslan
Bülent Aslan
GEGazanfer Ekinci
Gazanfer Ekinci

23 August 2022 in Clinical Imaging
Verified
Journal Article
Closed access
IEIlkay Ergenc
Ilkay Ergenc
HKHaluk Tarik Kani
Haluk Tarik Kani
CGCemal Aydin Gundogmus
Cemal Aydin Gundogmus
RERabia Ergelen
Rabia Ergelen
NSNaime Afsar Satis
Naime Afsar Satis
MAMehmet Pamir Atagunduz
Mehmet Pamir Atagunduz

11 May 2024 in Journal of Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
DCDilek Cavusoglu
Dilek Cavusoglu
BTBeril Talim
Beril Talim
GEGazanfer Ekinci
Gazanfer Ekinci
HTHaluk Topaloglu
Haluk Topaloglu
Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.